Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-02-24 @ 3:13 PM
Study NCT ID:
NCT03308357
Status:
UNKNOWN
Last Update Posted:
2017-10-13
First Post:
2017-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
Sponsor:
The Alfred
Organization: